BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35016131)

  • 1. Corrigendum to "Rim enhancement on hepatobiliary phase of pre-treatment 3.0 T MRI: A potential marker for early chemotherapy response in colorectal liver metastases treated with XELOX" [Eur. J. Radiol. 143 (2021) 109887].
    Wang X; Wang Y; Zhang Z; Zhou M; Zhou X; Zhao H; Xing J; Zhou Y
    Eur J Radiol; 2022 Mar; 148():110154. PubMed ID: 35016131
    [No Abstract]   [Full Text] [Related]  

  • 2. Rim enhancement on hepatobiliary phase of pre-treatment 3.0 T MRI: A potential marker for early chemotherapy response in colorectal liver metastases treated with XELOX.
    Wang X; Wang Y; Zhang Z; Zhou M; Zhou X; Zhao H; Xing J; Zhou Y
    Eur J Radiol; 2021 Oct; 143():109887. PubMed ID: 34454297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA "uptake" on the hepatobiliary phase of MR imaging.
    Granata V; Catalano O; Fusco R; Tatangelo F; Rega D; Nasti G; Avallone A; Piccirillo M; Izzo F; Petrillo A
    Abdom Imaging; 2015 Oct; 40(7):2364-71. PubMed ID: 26105523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to "Effects of menstrual cycle on background parenchymal enhancement and detectability of breast cancer on dynamic contrast-enhanced breast MRI: A multicenter study of an Asian population" [Eur. J. Radiol. 110 (2019) 130-135].
    Kamitani T; Yabuuchi H; Kanemaki Y; Tozaki M; Sonomura T; Mizukoshi W; Nakata W; Shimono T; Urano M; Yamano T; Kato F; Kuchiki M; Shiraga N; Yanagita H; Katsuda E; Kataoka M; Yamaguchi K; Horikoshi T; Gomi T; Nozaki M; Shiotani M; Amano M; Saigusa H; Sadaoka S; Kamiya H; Kubo M; Yamashita N; Yamamoto H; Honda H
    Eur J Radiol; 2019 May; 114():192. PubMed ID: 30954326
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "RECIST 1.1, Choi and mChoi criteria in the evaluation of tumor response in patients with metastatic colorectal cancer treated with Regorafenib and anti-PD-1 antibody" [Eur. J. Radiol. 141 (2021) 109823].
    Li L; Xu Y; Yang Y; Ye F; Zhang H; Zhou A; Zhao X
    Eur J Radiol; 2021 Sep; 142():109897. PubMed ID: 34371308
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Thermal-ablation of vertebral metastases prevents adverse events in patients with differentiated thyroid carcinoma" [Eur. J. Radiol. 119 (2019) 108650].
    Barat M; Tselikas L; de Baère T; Gravel G; Yevich S; Delpla A; Magand N; Louvel G; Hadoux J; Berdelou A; Terroir M; Baudin E; Schlumberger M; Leboulleux S; Deschamps F
    Eur J Radiol; 2019 Dec; 121():108693. PubMed ID: 31594669
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Improving contrast enhancement in pulmonary CTA: The value of breathing maneuvers" [Eur J Radiol Open 7 (2020) 100280].
    Manava P; Galster M; Schoen M; Ficker J; Lell MM; Adamus R; Bruch M
    Eur J Radiol Open; 2021; 8():100356. PubMed ID: 34041308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum to "3T MRI in paediatrics: Challenges and clinical applications" [Eur. J. Radiol. 68 (2) (2008) 309-319].
    Dagia C; Ditchfield M
    Eur J Radiol; 2014 Dec; 83(12):2294. PubMed ID: 28859936
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Effect of visceral fat area on the accuracy of preoperative CT-N staging of colorectal cancer" [Eur. J. Radiol. 168 (2023) 111131].
    Xie M; Liu G; Dong Y; Yu L; Song R; Zhang W; Zhang Y; Huang S; He J; Xiao Y; Long L
    Eur J Radiol; 2024 Jan; 170():111253. PubMed ID: 38159330
    [No Abstract]   [Full Text] [Related]  

  • 10. "Nondefect" of arterial enhancing rim on hepatobiliary phase in 3.0-T gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced liver magnetic resonance imaging: distinguishing hepatic abscess from metastasis.
    Choi SH; Lee CH; Kim BH; Lee J; Choi JW; Park YS; Kim KA; Park CM
    J Comput Assist Tomogr; 2013; 37(6):849-55. PubMed ID: 24270105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrahepatic mass-forming cholangiocarcinoma: enhancement pattern on Gd-BOPTA-MRI with emphasis of hepatobiliary phase.
    Mamone G; Marrone G; Caruso S; Carollo V; Gentile G; Crino' F; Milazzo M; Luca A
    Abdom Imaging; 2015 Oct; 40(7):2313-22. PubMed ID: 25962708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum to "MRI radiomics for the preoperative evaluation of lymphovascular invasion in breast cancer: A meta-analysis" [Eur. J. Radiol. 168 (2023) 111127].
    Ma Q; Li Z; Li W; Chen Q; Liu X; Feng W; Lei J
    Eur J Radiol; 2024 Jan; 170():111226. PubMed ID: 38056346
    [No Abstract]   [Full Text] [Related]  

  • 13. Late gadolinium MRI enhancement of colorectal liver metastases is associated with overall survival among nonsurgical patients.
    Cheung HMC; Kim JK; Hudson J; Coburn N; Karanicolas PJ; Law C; Milot L
    Eur Radiol; 2019 Jul; 29(7):3901-3907. PubMed ID: 30937587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy.
    Hosseini-Nik H; Fischer SE; Moulton CA; Karbhase G; Menezes RJ; Gallinger S; Jhaveri KS
    Abdom Radiol (NY); 2016 Feb; 41(2):231-8. PubMed ID: 26867904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases.
    Shin NY; Kim MJ; Lim JS; Park MS; Chung YE; Choi JY; Kim KW; Park YN
    Eur Radiol; 2012 Apr; 22(4):864-71. PubMed ID: 22108766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum to "Assessing the progression of segmental fibrosis in chronic liver disease using extracellular volume fractions" [Eur. J. Radiol. 145 (2021) 110033].
    Ozaki K; Ishida T; Ohtani T; Shimada M; Kimura H; Gabata T
    Eur J Radiol; 2022 Mar; 148():110179. PubMed ID: 35086003
    [No Abstract]   [Full Text] [Related]  

  • 17. Neoadjuvant therapy of bevacizumab in combination with oxaliplatin and capecitabine (XELOX) for patients with metastatic colorectal cancer with unresectable liver metastases: a phase II, open-label, single-arm, noncomparative trial.
    Chen HH; Lin JK; Chen JB; Chuang CH; Liu MC; Wang JY; Changchien CR
    Asia Pac J Clin Oncol; 2018 Feb; 14(1):61-68. PubMed ID: 28906589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corrigendum to "Meta-analysis of the efficacy of preoperative biliary drainage in patients undergoing liver resection for perihilar cholangiocarcinoma" [Eur. J. Radiol. 125 (2020) 108897].
    Mehrabi A; Khajeh E; Ghamarnejad O; Nikdad M; Chang DH; Büchler MW; Hoffmann K
    Eur J Radiol; 2020 Jul; 128():109004. PubMed ID: 32361382
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatobiliary phase enhancement of liver metastases on gadoxetic acid MRI: assessment of frequency and patterns.
    Bhayana R; Baliyan V; Kordbacheh H; Kambadakone A
    Eur Radiol; 2021 Mar; 31(3):1359-1366. PubMed ID: 32886204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of liver lesions hyperintense on hepatobiliary phase: an approach by clinical setting.
    Vernuccio F; Gagliano DS; Cannella R; Ba-Ssalamah A; Tang A; Brancatelli G
    Insights Imaging; 2021 Jan; 12(1):8. PubMed ID: 33432491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.